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Does collimation affect patient dose in antero-posterior thoraco-lumbar spine? 
 
 
ABSTRACT 
 
BACKGROUND: The purpose of this study is to determine the effect of collimation on the lifetime attributable 
risk (LAR) of cancer incidence in all body organs (effective risk) in patients undergoing antero-posterior (AP) 
examinations of the spine.  This is of particular importance for patients suffering from scoliosis as in their case 
regular repeat examinations are required and also because such patients are usually young and more 
susceptible to the effects of ionising radiation than are older patients. 
METHOD: High sensitivity thermo-luminescent dosimeters (TLDs) were used to measure radiation dose to all 
organs of an adult male dosimetry phantom, positioned for an AP projection of the thoraco-lumbar spine.  
Exposures were made, first applying tight collimation and then subsequently with loose collimation, using the 
same acquisition factors.  In each case, the individual TLDs were measured to determine the local absorbed 
dose and those representing each organ averaged to calculate organ dose. 
This information was then used to calculate the effective risk of cancer incidence for each decade of life from 
20 to 80, and to compare the likelihood of cancer incidence when using tight and loose collimation. 
RESULTS: The calculated figures for effective risk of cancer incidence suggest that the risk when using loose 
collimation compared to the use of tight collimation is over three times as high and this is the case across all 
age decades from 20 to 80. 
CONCLUSION: Tight collimation can greatly reduce radiation dose and risk of cancer incidence.  However 
collimation in scoliotic patients can be necessarily limited. 
 
Keywords:  Collimation, radiation dose, lifetime attributable risk, cancer incidence, thoraco-lumbar spine, 
scoliosis. 
 
 
INTRODUCTION 
 
The reduction of ionising radiation dose in radiography, whilst at the same time achieving images of optimum 
quality, is of paramount importance. One of the most important factors to attain this is by appropriate 
collimation of the primary X-ray beam.  Aside from the potential for dose reduction, accurate and tight 
collimation can result in an improvement of image quality by reduction of scatter1. 
 
Surprisingly little empirical research has been reported in the literature with regard to collimation and dose 
reduction.  Powys et al2, for example, performed three levels of collimation of a lateral projection of the facial 
bones and determined the comparative doses to the thyroid and the lens of the eye, using a head and thorax 
phantom and an Unfors dose meter. They found an appreciable reduction in dose to the thyroid with tighter 
collimation, although less so to the lenses of the eyes. Lee et al3 examined the effects of 'stepwise collimation' 
in scoliosis but employed only mathematically simulated dose estimations using tissue-weighting factors and a 
Monte Carlo method.  They found that there were large decreases in effective dose generally, but less so to 
organs in the target site of the examination.  They also pointed out that, depending upon the extent of the 
scoliosis, accurate collimation can be difficult due to the nature of the condition. 
 
Limitations of the use of a single dose meter2 and no direct dose measurements3, suggest that improvements 
can be made to the experimental design of previous research to investigate how dose varies between tight 
and loose collimation. This should lead to more accurate data on which to develop arguments. Our work 
builds directly on this previous research through the use of TLDs in a human dosimetry phantom in order to 
make more accurate estimations of organ dose. Using organ dose, effective dose and effective risk of 
radiation-induced cancer was then calculated. 
 
For the purposes of our investigation, the thoraco-lumbar spine was chosen and antero-posterior (AP) 
projections performed on a phantom.  One reason for this is that to determine the extent and progression of 
scoliosis, X-ray examinations of this area are repeated on a regular basis during the earlier years of life when 
the body is more susceptible to the adverse effects of ionising radiation4.  This will have an obvious impact on 
the effective risk of cancer incidence for such patients.  Another reason for this choice of area is that, as 
mentioned by Zetterberg et al5, one of the highest effective radiation doses in general radiography is found in 
lumbar spine examinations. 
 
The purpose of our work is to determine whether differences to organ dose, effective dose and effective risk 
for a range of ages exist when using tight collimation compared to loose collimation, as defined in the Data 
Acquisition section below.  The effects on male patients only are considered as the phantom used was male in 
structure. 
 
 
METHOD 
 
Our method uses an adult male dosimetry phantom with installed thermo-luminescent dosimeters (TLDs). 
This was exposed under tight and loose collimation for AP spine (see Figures 1 and 2). Using the TLD data, 
organ dose and effective dose were calculated along with effective risk for a range of ages. 
 
Dosimetry measurements 
A CIRS  (Computerized Imaging Reference Systems Inc.)  Atom model 701-D adult male dosimetry phantom 
was used for direct dose measurements and included 271 locations for TLD placement (CIRS, Norfolk Virginia).  
Annealed TLDs (TLD100H [LiF: Mg, Cu, P] (Thermo Fisher Scientific, Waltham, Massachusetts) were placed in 
each location for the exposures. The charges on the exposed TLDs were read using a Harshaw 3500 TLD 
reader (Thermo Fisher Scientific, Waltham, Massachusetts).  Prior to use, the TLDs were grouped into batches 
of similar response.  Calibration exposures at 75kVp and various mAs values were then applied directly to the 
TLDs with a source distance of 100cm.  These were completed for randomly-selected TLDs from each group 
along with an Unfors Mult-O-Meter 401 (Billdal, Sweden) in order to produce calibration factors for each 
group, as seen in Table 1.  These calibration factors, along with readings of background radiation, were 
applied to the raw exposure figures obtained from the phantom TLDs (see Table 2). Great care was taken to 
position each specific TLD in exactly the same location within the phantom for both tight and loose collimation 
exposures in order to account for any variation in response between different individual TLDs. 
 
Imaging equipment 
X-ray exposures were made using a Wolverson Arcoma Arco general radiography system (Arcoma, 
Annavägen, Sweden) with a Varian 130 HS X-ray tube and high-frequency generator.  Total filtration was 3mm 
Al (inherent 0.5mm, added 2.5mm Al). Quality control of the X-ray system was performed, including tube 
output; kV accuracy; AEC consistency and repeatability; and light beam alignment, centring and collimation, 
and the results fell within local and manufacturer's tolerances in compliance with the Institute of Physics and 
Engineering in Medicine (IPEM) Report 32. 
 
Data acquisition 
Two sets of AP projection exposures were made of the phantom.  In each case, ten exposures at one minute 
intervals were made and then the dose readings averaged in order to account for any random error in output 
of the X-ray system6,7.  The first acquisition, using tight collimation, was set to the width of the thoraco-lumbar 
spine to include the pedicles laterally, the sacro-iliac joints inferiorly and as much as possible superiorly using 
a 35x43cm sensor, the physical measurement of the collimated field at the front surface of the phantom being 
10cm wide and 46 cm tall (see Figure 1). For the second acquisition (loose collimation), the lateral collimation 
was opened to include the full width of the trunk, 38cm wide (see Figure 2). We acknowledge that backscatter 
would increase with loose collimation but we have not attempted to quantify this. These two scenarios 
accommodate the two extremes of lateral collimation for AP spine when imaging scoliosis. 
 
Exposure factors for the phantom were 75kVp and 16mAs at a SID (Source to Image receptor Distance) of 
180cm.  The choice of kVp was based on the work of Al Qaroot et al8.  Initial test exposures were performed 
using the Automatic Exposure Control (AEC) to determine the optimum mAs value, and this was set manually 
for all subsequent tight and loose collimation exposures with the aim of delivering a consistent tube output. 
 
Analysis 
For each TLD, the average group background radiation was subtracted from the raw exposure reading and the 
resulting figure divided by ten to account for the ten exposures made.  That figure was then multiplied by the 
TLD group calibration factor in order to account for variations in TLD sensitivity and to ensure that resultant 
dose figures in mGy relate to the nanocoulomb (nC) readings on the TLDs (see Table 2). 
 
The average dose for all of the TLDs representing each organ were calculated. These figures were then 
multiplied by the estimates given in Table 12D-1 Lifetime Attributable Risk of Cancer Incidence of BEIR VII 
Phase4 for each decade of life, the figures used being for male patients only as a male dosimetry phantom was 
used.  As the BEIR VII figures represent the Lifetime Attributable Risk (LAR) of cancer incidence in number of 
cases per 100,000 persons exposed to a single dose of 0.1 Gy, they have been adjusted to represent the 
number of cases per 1,000,000 persons exposed to the given doses in mGy. 
 
Effective dose was calculated using the following equation:  
𝐸 =∑𝑊T
T
∑𝑊R𝐷T,R
R
 
Where WRDT,R is the equivalent dose in a tissue or organ, T, and WT is the tissue weighting factor  
and the tissue-weighting factors stated in ICRP report 1039.  The Radiation Weighting Factor for photons (eg, 
X-rays) is 1. 
 
 
RESULTS 
 
Table 3 compares the LAR of radiation-induced cancer in different body organs and the effective risk (the 
total) in number of cases per 1,000,000 persons exposed for each decade of life when using tight collimation 
and loose collimation.  Figure 3 presents the same information graphically.  Table 4 shows the increase in 
average organ dose in mGy for each of the listed organs when using loose collimation compared to tight 
collimation, and includes the percentage change to organ dose for each organ when collimation of the X-ray 
beam is opened from tightly-collimated to a much wider field as may be necessary in cases of severe scoliosis.  
The effective organ dose in mSv for each organ (after adjustment for tissue-weighting) using tight and loose 
collimation is given in Table 5 for comparison.  Effective dose figures are calculated by totalling the tissue-
weighted doses of all organs. 
 
The calculated figures for LAR of cancer incidence as a result of a single exposure of X-rays using the data 
acquisition factors given earlier, across age decades from 20s to 80s, are indicated in Table 3.  The figures for 
each individual organ are combined to produce effective risk for each age decade, and the figures for tight 
collimation and loose collimation are presented adjacent to each other for ease of comparison.  In each case, 
the figures suggest that the risk when using loose collimation is over three times as high as when using tight 
collimation (p=0.001). Specifically, the numbers show an increase of effective risk  by a factor of 3.22 at age 
20, 3.24 at age 30, 3.27 at age 40, 3.30 at age 50, 3.36 at age 60, 3.43 at age 70 and 3.66 at age 80 when using 
loose collimation compared with tight collimation to the degree used in this experiment. Quite apart from the 
substantial reductions due to the use of tight collimation, the LAR decreases considerably with increase in age, 
as shown in Figure 3. 
 
 
DISCUSSION 
 
Table 4 shows an increase in organ dose to all organs when using loose compared to tight collimation 
(p=0.016).  As might be expected, the greatest percentage increase is found in the lungs and the colon (571%  
and 305% respectively), as large areas of these organs are outside the area directly irradiated when tight 
collimation is used.  However, there is still a notable increase in organs which are outside of the primary beam 
with both tight and loose collimation, for example the thyroid, prostate and bladder (which increase by 150%,  
83.7% and 31% respectively), and this may be accounted for by the increase in scattered radiation from the 
much larger area of the abdomen irradiated. 
 
A different picture emerges when tissue-weighted dose (see Table 5) is considered.  Here, whilst the lungs are 
still subject to a large increase, the colon is much less affected and the second highest percentage increase is 
seen in 'other' organs (which includes active bone marrow, brain, oesophagus, thymus, breast, heart, spleen, 
adrenals, kidneys, pancreas, gall bladder, small intestine and testes).  This is presumably due to the relatively 
high sensitivity of active bone marrow to ionising radiation. Other named organs show relatively little 
difference between organ dose increase and tissue-weighted dose increase. 
 
Exposure to the testes (included in the 'Other' figures shown) was measured using only two TLDs and showed 
very low organ doses: tight collimation = 0.0004 mGy, loose collimation = 0.001 mGy.  These were, of course, 
outside of the irradiated areas in both cases and yet the increase (more than double) could be accounted for 
by increased scatter. 
 
The breasts, also represented by only two TLDs, showed a much larger increase (25 times) in organ dose from 
tight collimation (0.0056 mGy) to loose collimation (0.1404 mGy).  In this case, however, the breasts were 
outside the tightly collimated beam but well within the loosely collimated beam.  As this study was done using 
a male phantom, it is likely that a more representative difference would be noticed if a female phantom (or 
female breast attachments to the male phantom) were to be used, providing more TLD locations to represent 
breast dose.  Further investigations are to be recommended.  Doses to the ovaries were not measured for the 
same reason. Should they have been measured, they would have been near inclusion in the tight collimation 
beam and almost certainly included in loose collimation exposures.  In addition, the factors in Table 12-1 
produced by the National Academy of Sciences4, and used for our study, were those for male patients and the 
equivalents for female patients are quite different and in general higher.  Again, further investigations should 
be done for female doses and LAR of cancer incidence. 
 
As mentioned, all of these measurements were obtained using a setting of 75kVp, based on the work of Al 
Qaroot et al8.  It is quite likely, however, that a high kVp technique might be used for the purposes of 
measuring Cobb angles, as in scoliosis, and where a clear image of the outlines of the vertebral bodies is of 
more importance than bony detail.  Had a higher kVp setting been used for this experiment, it is almost 
certain that the TLD readings would have been different.  Again, further investigations might be in order. 
 
Whereas the effective risk of cancer incidence is much higher when the primary beam is less collimated 
(wider), it is noticeable that this is much less important for older people, as is clearly shown in Figure 3.  On 
the contrary, the most heavily affected are the youngest patients (age 20 in our study) and this is the age 
range where repeated examinations for scoliosis are often undertaken.  It should be mentioned that accurate 
figures for paediatric patients were not obtained in our experiment as the phantom used was of adult size.  
Further investigations could be done using a smaller phantom to represent such patients.  Lateral projections 
of the same area could also form the basis of a follow-up investigation, although in this case the difference 
between achievable tight and loose collimation would be a great deal less.  
 
Although it is good practice to collimate the X-ray beam to the optimum dimensions, there is also the 
likelihood of over-collimating, especially in scoliosis, and in so doing failing to include all areas of interest.  This 
would necessitate repeat exposures with the resultant doubling (or more, when less collimation would be 
used) of radiation dose.  It is suggested that, in scoliosis examinations, collimation should err on the side of 
inclusion at least in the first instance and then follow-up examinations could be subject to tighter collimation 
when the extents and severity of scoliosis is known. It is also accepted that increasing the width of the 
collimated X-ray field will result in increased scatter to the detriment of the quality of the resultant image.  
However, this would be unavoidable in cases of severe scoliosis. 
 
 
CONCLUSION 
 
It stands to reason that by reducing the field size, dose will be reduced and our study has served to quantify 
the effects in a practical situation and, in addition, to relate dose to the LAR of cancer incidence for each 
decade of adult life. 
 
The use of tight collimation, then, is to be recommended although this may be greatly limited in cases of 
severe scoliosis.   
 
  
Table 1 – Example of group calibration table 75kVp 
mAs 
Unfors 
dose 
(mGy) 
TLD 
1 2 3 
Average 
Average less 
background No. 
Charge 
(nC) 
No. 
Charge 
(nC) 
No. 
Charge 
(nC) 
10 0.271 A1 11.110 A2 11.060 A3 10.790 10.987 10.889 
30 0.888 B1 33.720 B2 35.960 B3 32.700 34.127 34.029 
50 1.396 C1 55.950 C2 58.750 C3 56.650 57.117 57.019 
70 1.988 D1 77.280 D2 82.690 D3 78.560 79.510 79.412 
90 2.529 E1 102.900 E2 98.980 E3 98.960 100.280 100.182 
Background   F1 0.097 F2 0.100 F3 0.096 0.098   
 
 
 
 
Table 2 – Extract from TLD readings table 
  Experiment location: Room 1   Collimation: TIGHT   Exposures date: 4.4.16 
  kVp = 75 mAs = 16 SID = 180 Grid 
 
Readings date: 4-5.4.16 
  (ABM = Active Bone Marrow   TLD gp BR = TLD group background radiation   TLD gp CF = TLD group calibration factor) 
TLD 
no. 
Organ 
Phantom 
slice no. 
Depth 
TLD gp 
& no on 
tray 
TLD 
reading  
(10 exp) in 
nC 
TLD gp 
BR 
TLD 
reading   
– TLD gp 
BR 
TLD 
reading 
mean 
(/10) 
TLD gp 
CF 
TLD 
reading   
* TLD gp 
CF 
54 R Lung 14 5 2a 5.7760 0.0977 5.6783 0.5678 0.0251 0.0143 
55 Sternum (ABM) 14 20 2a 6.7340 0.0977 6.6363 0.6636 0.0251 0.0167 
56 L Thymus 14 12 2a 8.7850 0.0977 8.6873 0.8687 0.0251 0.0218 
57 R Thymus 14 12 2a 7.8640 0.0977 7.7663 0.7766 0.0251 0.0195 
58 L Ribs (ABM) 14 3 2a 1.4440 0.0977 1.3463 0.1346 0.0251 0.0034 
59 L Ribs (ABM) 14 3 2a 1.1620 0.0977 1.0643 0.1064 0.0251 0.0027 
60 L Ribs (ABM) 14 3 2a 1.7660 0.0977 1.6683 0.1668 0.0251 0.0042 
61 R Ribs (ABM) 14 3 2a 3.5440 0.0977 3.4463 0.3446 0.0251 0.0087 
62 R Ribs (ABM) 14 3 2a 1.3060 0.0977 1.2083 0.1208 0.0251 0.0030 
63 R Ribs (ABM) 14 3 2a 1.2390 0.0977 1.1413 0.1141 0.0251 0.0029 
64 L Scapula (ABM) 14 5 2a 0.6547 0.0977 0.5570 0.0557 0.0251 0.0014 
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Figure 1 – Photograph and radiograph showing extents of tight collimation 
  
 
 
Figure 2 – Photograph and radiograph showing extents of loose collimation 
 
 
Table 3 – Lifetime attributable risk calculations 
  
Average 
dose (mGy) 
Average 
dose(mGy) Lifetime Attributable Risk of cancer incidence - number of cases per 1,000,000 persons exposed 
Organ 
Tight 
collimation 
Loose 
collimation 
age 20 
x Tight Loose 
age 30 
x Tight Loose 
age 40 
x Tight Loose 
Stomach 0.031224 0.074714 4.00 0.124896 0.298854 2.80 0.087427 0.209198 2.70 0.084305 0.201727 
Colon 0.016622 0.067286 17.30 0.287569 1.164053 12.50 0.207781 0.841079 12.20 0.202794 0.820893 
Liver 0.029591 0.064113 3.00 0.088772 0.192339 2.20 0.065100 0.141049 2.10 0.062140 0.134637 
Lungs 0.007196 0.048305 14.90 0.107226 0.719741 10.50 0.075562 0.507200 10.40 0.074842 0.502370 
Prostate 0.001197 0.002199 4.80 0.005746 0.010556 3.50 0.004190 0.007697 3.50 0.004190 0.007697 
Bladder 0.010014 0.013119 10.80 0.108156 0.141688 7.90 0.079114 0.103642 7.90 0.079114 0.103642 
Thyroid 0.001555 0.003891 2.10 0.003265 0.008171 0.90 0.001399 0.003502 0.30 0.000466 0.001167 
Other 0.007809 0.018833 31.20 0.243641 0.587597 19.80 0.154618 0.372898 17.20 0.134315 0.323932 
Effective risk       0.969270 3.122999   0.675191 2.186264   0.642167 2.096064 
 
  
 
Lifetime Attributable Risk of cancer incidence - number of cases per 1,000,000 persons exposed 
Organ 
age 
50 x Tight Loose 
age 60 
x Tight Loose 
age 70 
x Tight Loose 
age 
80 x Tight Loose 
Stomach 2.50 0.078060 0.186784 2.00 0.062448 0.149427 1.40 0.043714 0.104599 0.07 0.002186 0.005230 
Colon 11.30 0.187834 0.760335 9.40 0.156251 0.632491 6.50 0.108046 0.437361 3.00 0.049867 0.201859 
Liver 1.90 0.056222 0.121815 1.40 0.041427 0.089758 0.80 0.023673 0.051290 0.30 0.008877 0.019234 
Lungs 10.10 0.072683 0.487878 8.90 0.064048 0.429912 6.50 0.046776 0.313981 3.40 0.024468 0.164236 
Prostate 3.30 0.003950 0.007257 2.60 0.003112 0.005718 1.40 0.001676 0.003079 0.50 0.000599 0.001100 
Bladder 7.60 0.076110 0.099706 6.60 0.066096 0.086587 4.70 0.047068 0.061660 2.30 0.023033 0.030174 
Thyroid 0.10 0.000155 0.000389 0.03 0.000047 0.000117 0.01 0.000016 0.000039 0.00 0.000000 0.000000 
Other 14.00 0.109326 0.263665 9.80 0.076528 0.184566 5.70 0.044511 0.107349 2.30 0.017961 0.043316 
Effective risk   0.584341 1.927830   0.469956 1.578576   0.315479 1.079359   0.126990 0.465149 
('Other' represents all other organs including active bone marrow) 
 
 
Figure 3 – Graphical representation of lifetime attributable risk calculations  
 
 
 
 
 
 
 
 
 
 
Table 4 – Increase in organ dose from tight to loose collimation 
  Organ dose  (mGy)     
Organ Tight collimation Loose collimation Increase % increase 
Stomach 0.031224 0.074714 0.043490 139.28% 
Colon 0.016622 0.067286 0.050664 304.79% 
Liver 0.029591 0.064113 0.034522 116.67% 
Lungs 0.007196 0.048305 0.041108 571.24% 
Prostate 0.001197 0.002199 0.001002 83.72% 
Bladder 0.010014 0.013119 0.003105 31.00% 
Thyroid 0.001555 0.003891 0.002336 150.24% 
Other 0.007809 0.018833 0.011024 141.17% 
 
 
Table 5 – Increase in tissue-weighted dose from tight to loose collimation 
  Tissue-weighted dose  (mSv)     
Organ Tight collimation Loose collimation Increase % increase 
Stomach 0.003747 0.008966 0.005219 139.28% 
Colon 0.001995 0.004515 0.002520 126.35% 
Liver 0.001184 0.002565 0.001381 116.67% 
Lungs 0.000864 0.005797 0.004933 571.24% 
Prostate 0.000013 0.000024 0.000011 83.72% 
Bladder 0.000401 0.000525 0.000124 31.00% 
Thyroid 0.000062 0.000156 0.000093 150.24% 
Other 0.000282 0.001737 0.001455 516.85% 
Effective dose 0.008546 0.024283 0.015737   
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